NCT06005987Recruiting
Mobile App Logging for Diabetes in Pregnancy
Effect of a Mobile Application on Blood Sugar Testing Compliance in Pregnant Women With Diabetes
Source: ClinicalTrials.gov · Last updated 31 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 16 Aug 2023
- Start date
- 1 Jun 2024
- Primary completion date
- 1 Jan 2027
- Lead sponsor
- Carolyn Zahler-Miller
- Diseases
- Type 2 diabetes
- NCT number
- NCT06005987
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 1 Jun 2024 to the primary completion date, 1 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Type 1 diabetes mellitus
Lab values
- Pre-existing use of a continuous glucose monitor or other mobile application for glucose tracking
Other
- Patients with less than 4 weeks anticipated to be remaining in pregnancy
- Non-English speaking patients
Who the study is looking for
- 18 years and older
- Verified intrauterine pregnancy
- At least 12 weeks gestation
- Diagnosed with either type 2 diabetes mellitus or gestational diabetes mellitus.
Age in the registry: 18 years to 100 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Augusta University Coordinator of this site? Confirm its status | Augusta | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.